Related Experiment Video

Updated: Jul 18, 2026

Real-Time Monitoring of Neurocritical Patients with Diffuse Optical Spectroscopies

Real-Time Monitoring of Neurocritical Patients with Diffuse Optical Spectroscopies

Published on: November 19, 2020

Measuring cognitive outcome after subarachnoid hemorrhage

E Clarke Haley¹

¹Department of Neurology and Neurosurgery, University of Virginia Stroke Center, University of Virginia Health System, Charlottesville, VA.

Annals of Neurology

|November 23, 2006

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.

JAMA neurology·2020

Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.

Annals of neurology·2018

Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection.

Stroke·2016

Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.

International journal of stroke : official journal of the International Stroke Society·2016

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial.

The Lancet. Neurology·2014

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design.

Clinical trials (London, England)·2011

See all related articles